Effect modification of hyperlipidemia and hypertension on the association between type 2 diabetes and gout.
Prim Care Diabetes
; 14(6): 654-662, 2020 12.
Article
en En
| MEDLINE
| ID: mdl-32593565
ABSTRACT
AIMS:
We evaluated the association between type 2 diabetes and gout by a retrospective cohort study.METHODS:
Data of 17,259 male and 18,318 female patients with type 2 diabetes were retrieved for the 1998-2010 period. These patients were matched to a comparison group (n=34,518 and n=36,636, respectively) in a 12 ratio by age and region.RESULTS:
We found that patients with type 2 diabetes after adjustment for hyperlipidemia and hypertension had a lower risk of incident gout than the matched population (incidence rate ratio, men 0.39 [95% CI 0.36-0.42]; women 0.78 [0.72-0.84]). Specifically, type 2 diabetes alone without hyperlipidemia and hypertension was associated with a reduced risk of incident gout in men (adjusted relative risk [RR] 0.29, 95% CI 0.22-0.39), but not in women (0.86, 95% CI 0.55-1.36). We found that insulin users with hyperlipidemia and hypertension associated with risk of incident gout and no sex-specific differences were noted (adjusted RR, men 1.28 [95% CI 1.11-1.48]; women 1.32 [95% CI 1.14-1.53]). Specifically, insulin users alone without hyperlipidemia and hypertension were not statistically significantly associated with gout risk (P≥.0954).CONCLUSIONS:
The results of this study indicated that hyperlipidemia and hypertension modified the association between type 2 diabetes and gout.Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Diabetes Mellitus Tipo 2
/
Gota
/
Hiperlipidemias
/
Hipertensión
Tipo de estudio:
Diagnostic_studies
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Male
Idioma:
En
Año:
2020
Tipo del documento:
Article